These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37866519)

  • 1. Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura.
    De Waele L; Sakai K; Mancini I; Sinkovits G; Falter T; Inoue T; Agosti P; Rossmann H; Von Auer C; Tersteeg C; De Meyer SF; Joly BS; Veyradier A; Coppo P; Fijnheer R; Peyvandi F; Prohászka Z; Lämmle B; Vanhoorelbeke K
    J Thromb Haemost; 2024 Feb; 22(2):493-502. PubMed ID: 37866519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional study.
    Schieppati F; Russo L; Marchetti M; Barcella L; Cefis M; Gomez-Rosas P; Caldara G; Carpenedo M; D'Adda M; Rambaldi A; Savignano C; Billio A; Bruno Franco M; Toschi V; Falanga A
    Am J Hematol; 2020 Aug; 95(8):953-959. PubMed ID: 32350923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of thrombotic thrombocytopenic purpura: easy-to-use fiber optic surface plasmon resonance immunoassays for automated ADAMTS-13 antigen and conformation evaluation.
    Bonnez Q; Dekimpe C; Bekaert T; Tellier E; Kaplanski G; Joly BS; Veyradier A; Coppo P; Lammertyn J; Tersteeg C; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2024 Jul; 22(7):1936-1946. PubMed ID: 38554935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura.
    Roose E; Schelpe AS; Joly BS; Peetermans M; Verhamme P; Voorberg J; Greinacher A; Deckmyn H; De Meyer SF; Coppo P; Veyradier A; Vanhoorelbeke K
    J Thromb Haemost; 2018 Feb; 16(2):378-388. PubMed ID: 29222940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS-13 conformation influences autoimmune recognition in immune thrombotic thrombocytopenic purpura.
    Underwood MI; Thomas MR; Scully MA; Crawley JTB
    J Thromb Haemost; 2024 Apr; 22(4):1069-1079. PubMed ID: 38160729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura.
    Underwood MI; Alwan F; Thomas MR; Scully MA; Crawley JTB
    J Thromb Haemost; 2023 Jun; 21(6):1544-1552. PubMed ID: 36813118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura.
    Bettoni G; Palla R; Valsecchi C; Consonni D; Lotta LA; Trisolini SM; Mancini I; Musallam KM; Rosendaal FR; Peyvandi F
    J Thromb Haemost; 2012 Aug; 10(8):1556-65. PubMed ID: 22672482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura.
    Roose E; Schelpe AS; Tellier E; Sinkovits G; Joly BS; Dekimpe C; Kaplanski G; Le Besnerais M; Mancini I; Falter T; Von Auer C; Feys HB; Reti M; Rossmann H; Vandenbulcke A; Pareyn I; Voorberg J; Greinacher A; Benhamou Y; Deckmyn H; Fijnheer R; Prohászka Z; Peyvandi F; Lämmle B; Coppo P; De Meyer SF; Veyradier A; Vanhoorelbeke K
    Blood; 2020 Jul; 136(3):353-361. PubMed ID: 32356859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura.
    Postmus T; Graça NAG; Ferreira de Santana J; Ercig B; Langerhorst P; Luken B; Joly BS; Vanhoorelbeke K; Veyradier A; Coppo P; Voorberg J
    J Thromb Haemost; 2023 Dec; 21(12):3402-3413. PubMed ID: 37633643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpura.
    Prasannan N; Dragunaite B; Subhan M; Thomas M; de Groot R; Singh D; Vanhoorelbeke K; Scully M
    Blood; 2024 Jun; 143(25):2644-2653. PubMed ID: 38502824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpura.
    Comparon C; Galicier L; Rebibou JM; Coppo P; Benhamou Y
    Eur J Haematol; 2023 Feb; 110(2):157-160. PubMed ID: 36271897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study.
    Schieppati F; Russo L; Gamba S; Galimberti E; Giaccherini C; Tartari CJ; Bolognini S; Verzeroli C; Ticozzi C; Barcella L; Marchetti M; Falanga A
    Thromb Haemost; 2023 Oct; 123(10):945-954. PubMed ID: 37172940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The standard of care for immune thrombotic thrombocytopenic purpura today.
    Zheng XL
    J Thromb Haemost; 2021 Aug; 19(8):1864-1871. PubMed ID: 34060225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.
    Pascual-Izquierdo C; Del Rio-Garma J; de la Rubia J; Viejo A; Mingot E; Cid J; Solanich X; Fernández-Sojo J; Martín-Sánchez J; Hernández L; García-Gala JM; Alonso N; González V; Oliva A; Gómez-Seguí I; Goterris R; Guerra L; García-Candel F; Fernández-Docampo M; Antelo ML; Salgado-Barreira Á; Salinas R;
    J Clin Apher; 2021 Aug; 36(4):563-573. PubMed ID: 33780553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.
    Sui J; Cao W; Halkidis K; Abdelgawwad MS; Kocher NK; Guillory B; Williams LA; Gangaraju R; Marques MB; Zheng XL
    Blood Adv; 2019 Dec; 3(24):4177-4186. PubMed ID: 31856267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura.
    Sakai K; Matsumoto M; De Waele L; Dekimpe C; Hamada E; Kubo M; Tersteeg C; De Meyer SF; Vanhoorelbeke K
    Blood Adv; 2023 Jan; 7(1):131-140. PubMed ID: 36306339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
    Li A; Khalighi PR; Wu Q; Garcia DA
    J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura.
    Pavenski K; Huang SS; Patriquin CJ
    Expert Rev Hematol; 2021 Nov; 14(11):1027-1040. PubMed ID: 34747320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura.
    Brown J; Potugari B; Mazepa MA; Kohli R; Moliterno AR; Brodsky RA; Vaught JA; Burwick R; Chaturvedi S
    Ann Hematol; 2022 Oct; 101(10):2159-2167. PubMed ID: 35932324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura do not hamper ELISA-based quantification of ADAMTS13 antigen.
    Dekimpe C; Roose E; Tersteeg C; Joly BS; Dewaele A; Horta S; Pareyn I; Vandenbulcke A; Deckmyn H; Feys HB; Tellier E; Kaplanski G; Scully M; Coppo P; De Meyer SF; Veyradier A; Vanhoorelbeke K
    J Thromb Haemost; 2020 Apr; 18(4):985-990. PubMed ID: 31989742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.